Usher Syndrome Global Market Report 2025

Description

Usher syndrome is a genetic disorder that affects both hearing and vision, often resulting in deafness or hearing loss, along with a progressive eye condition known as retinitis pigmentosa (RP). It is the leading cause of combined deaf-blindness and follows an autosomal recessive inheritance pattern.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main categories in the Usher syndrome market are type 1, type 2, type 3, and other types. Type 1 Usher syndrome is the most severe form, characterized by profound deafness from birth, significant balance issues, and early-onset vision loss due to retinitis pigmentosa (RP). Treatment options include devices, drugs, therapy, and other methods. Diagnostic tools include electroretinograms, optical coherence tomography, video hysterography, audiology, genetic testing, and other assessments. Distribution channels include hospital pharmacies, retail pharmacies, and other outlets. End-users of these treatments include hospitals, specialty clinics, and other healthcare settings.

The usher syndrome market research report is one of a series of new reports from The Business Research Company that provides usher syndrome market statistics, including usher syndrome industry global market size, regional shares, competitors with an usher syndrome market share, detailed usher syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the usher syndrome industry. This usher syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The usher syndrome market size has grown strongly in recent years. It will grow from $2.13 billion in 2024 to $2.25 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth observed during the historic period can be attributed to the increasing prevalence of genetic disorders, a growing demand for minimally invasive surgeries, a rise in inherited disorders, more product approvals, and the expansion of government initiatives.

The usher syndrome market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth projected during the forecast period can be attributed to the increasing use of cochlear implants, a rise in gene mutations, growing healthcare expenditure, the increasing popularity of ophthalmological rehabilitation, and a greater adoption of audiological rehabilitation. Key trends during this period include the development of vaccines, advancements in hearing aids, innovations in medical devices, improvements in surgical techniques, and progress in gene therapies.

The growing prevalence of inherited disorders is expected to drive the expansion of the Usher syndrome market. Inherited disorders are genetic conditions passed from parents to their offspring through DNA, often due to mutations in one or more genes. The rise in inherited disorders is linked to increasing parental age, which leads to a higher incidence of genetic conditions in newborns. Usher syndrome, a genetic disorder, requires early diagnosis, specialized care, and targeted treatments. The growing awareness and screening for genetic conditions are resulting in more cases of Usher syndrome being identified, thereby increasing the demand for diagnostic tests, genetic counseling, and therapeutic interventions. For example, in November 2022, the United Kingdom Hemophilia Centre Doctors Organization reported an increase in new registrations for individuals aged 2 years and older with severe hemophilia A, rising from 16 in 2021 to 19 in 2022. Therefore, the rising prevalence of inherited disorders is expected to drive the growth of the Usher syndrome market.

Leading companies in the Usher syndrome market are focusing on clinical studies to develop gene therapies and innovative treatments aimed at slowing or reversing vision and hearing loss. These clinical studies seek to improve early diagnosis, enhance assistive technologies, and explore potential drug-based interventions for more effective disease management. For instance, in October 2024, AAVantgarde Bio, an Italy-based biotechnology company, launched the LUCE-1 trial, a Phase I/II clinical study to evaluate the safety and efficacy of its gene therapy, AAVB-081, for treating retinitis pigmentosa associated with Usher Syndrome type 1B (USH1B). The trial is designed to assess the safety and tolerability of AAVB-081, which delivers a functional copy of the MYO7A gene, essential for retinal health.

In December 2023, Laboratoires Thea, a France-based pharmaceutical company, acquired sepofarsen and ultevursen from ProQR Therapeutics for an undisclosed amount. This acquisition aims to further the clinical development of sepofarsen and ultevursen for treating inherited retinal diseases such as LCA10 and Usher syndrome 2A. ProQR Therapeutics NV, a biotechnology company based in the Netherlands, focuses on developing treatments for Usher syndrome type 2. This acquisition will enable Laboratoires Thea to advance these therapies, enhancing the potential treatment options for late-stage eye diseases.

Major players in the usher syndrome market are National Institute Of Health, Stanford Health Care, Cochlear Ltd, Advanced Bionics AG, Spark Therapeutics, Editas Medicine Inc, American Academy of Ophthalmology, BlueRock Therapeutics, Medline Plus, Ear Science Institute Australia, Oxford Academics, ProQR Therapeutics NV, ReiThera srl, Usher Syndrome Coalition, Happy Ears Hearing Center, Odylia Therapeutics, ReNeuron Group plc, Sensorion SAS, Gensight Biologics, Harvard Medical School.

North America was the largest region in the usher syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in usher syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the usher syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The usher syndrome market consists of revenues earned by entities by providing services such as audiology services, vision rehabilitation, genetic counseling, and mobility training. The market value includes the value of related goods sold by the service provider or included within the service offering. The usher syndrome market also includes sales of hearing aids, cochlear implants, assistive listening devices, and low-vision aids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Usher Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on usher syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for usher syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The usher syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Type 1; Type 2; Type 3; Other Types
2) By Treatment: Devices; Drugs; Therapy; Other Treatments
3) By Diagnosis: Electroretinogram; Optical Coherence Tomography; Video Nystagmography; Audiology; Genetic Testing; Other Diagnoses
4) By Distribution Channels: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channels
5) By End-Users: Hospitals; Speciality Clinics; Other End-Users
Subsegments:
1) By Type 1: MYO7A Mutation; USH1C Mutation; CDH23 Mutation; PCDH15 Mutation; USH1G Mutation
2) By Type 2: USH2A Mutation; GPR98 Mutation; DFNB31 Mutation
3) Type 3: CLRN1 Mutation
4) Other Types: Atypical Usher Syndrome; Rare Genetic Variants
Companies Mentioned: National Institute Of Health; Stanford Health Care; Cochlear Ltd; Advanced Bionics AG; Spark Therapeutics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35007

1. Executive Summary

2. Usher Syndrome Market Characteristics

3. Usher Syndrome Market Trends And Strategies

4. Usher Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Usher Syndrome Growth Analysis And Strategic Analysis Framework

5.1. Global Usher Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Usher Syndrome Market Growth Rate Analysis
5.4. Global Usher Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Usher Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Usher Syndrome Total Addressable Market (TAM)

6. Usher Syndrome Market Segmentation

6.1. Global Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type 1
Type 2
Type 3
Other Types
6.2. Global Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Devices
Drugs
Therapy
Other Treatments
6.3. Global Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electroretinogram
Optical Coherence Tomography
Video Nystagmography
Audiology
Genetic Testing
Other Diagnoses
6.4. Global Usher Syndrome Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Other Distribution Channels
6.5. Global Usher Syndrome Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Other End-Users
6.6. Global Usher Syndrome Market, Sub-Segmentation Of Type 1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
MYO7A Mutation
USH1C Mutation
CDH23 Mutation
PCDH15 Mutation
USH1G Mutation
6.7. Global Usher Syndrome Market, Sub-Segmentation Of Type 2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
USH2A Mutation
GPR98 Mutation
DFNB31 Mutation
6.8. Global Usher Syndrome Market, Sub-Segmentation Of Type 3, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CLRN1 Mutation
6.9. Global Usher Syndrome Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atypical Usher Syndrome
Rare Genetic Variants

7. Usher Syndrome Market Regional And Country Analysis

7.1. Global Usher Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Usher Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Usher Syndrome Market

8.1. Asia-Pacific Usher Syndrome Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Usher Syndrome Market

9.1. China Usher Syndrome Market Overview
9.2. China Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Usher Syndrome Market

10.1. India Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Usher Syndrome Market

11.1. Japan Usher Syndrome Market Overview
11.2. Japan Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Usher Syndrome Market

12.1. Australia Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Usher Syndrome Market

13.1. Indonesia Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Usher Syndrome Market

14.1. South Korea Usher Syndrome Market Overview
14.2. South Korea Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Usher Syndrome Market

15.1. Western Europe Usher Syndrome Market Overview
15.2. Western Europe Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Usher Syndrome Market

16.1. UK Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Usher Syndrome Market

17.1. Germany Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Usher Syndrome Market

18.1. France Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Usher Syndrome Market

19.1. Italy Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Usher Syndrome Market

20.1. Spain Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Usher Syndrome Market

21.1. Eastern Europe Usher Syndrome Market Overview
21.2. Eastern Europe Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Usher Syndrome Market

22.1. Russia Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Usher Syndrome Market

23.1. North America Usher Syndrome Market Overview
23.2. North America Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Usher Syndrome Market

24.1. USA Usher Syndrome Market Overview
24.2. USA Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Usher Syndrome Market

25.1. Canada Usher Syndrome Market Overview
25.2. Canada Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Usher Syndrome Market

26.1. South America Usher Syndrome Market Overview
26.2. South America Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Usher Syndrome Market

27.1. Brazil Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Usher Syndrome Market

28.1. Middle East Usher Syndrome Market Overview
28.2. Middle East Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Usher Syndrome Market

29.1. Africa Usher Syndrome Market Overview
29.2. Africa Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Usher Syndrome Market Competitive Landscape And Company Profiles

30.1. Usher Syndrome Market Competitive Landscape
30.2. Usher Syndrome Market Company Profiles
- 30.2.1. National Institute Of Health Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Stanford Health Care Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Cochlear Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Advanced Bionics AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Spark Therapeutics Overview, Products and Services, Strategy and Financial Analysis

31. Usher Syndrome Market Other Major And Innovative Companies

31.1. Editas Medicine Inc
31.2. American Academy of Ophthalmology
31.3. BlueRock Therapeutics
31.4. Medline Plus
31.5. Ear Science Institute Australia
31.6. Oxford Academics
31.7. ProQR Therapeutics NV
31.8. ReiThera srl
31.9. Usher Syndrome Coalition
31.10. Happy Ears Hearing Center
31.11. Odylia Therapeutics
31.12. ReNeuron Group plc
31.13. Sensorion SAS
31.14. Gensight Biologics
31.15. Harvard Medical School

32. Global Usher Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Usher Syndrome Market

34. Recent Developments In The Usher Syndrome Market

35. Usher Syndrome Market High Potential Countries, Segments and Strategies

35.1 Usher Syndrome Market In 2029 - Countries Offering Most New Opportunities
35.2 Usher Syndrome Market In 2029 - Segments Offering Most New Opportunities
35.3 Usher Syndrome Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250617_r35007_Usher_Syndrome_GMR_2025